Cathepsins and cystatin C in atherosclerosis and obesity.
about
Dietary factors impact on the association between CTSS variants and obesity related traitsMolecular dynamics simulation of halogen bonding mimics experimental data for cathepsin L inhibition.Systematic optimization of multiplex zymography protocol to detect active cathepsins K, L, S, and V in healthy and diseased tissue: compromise among limits of detection, reduced time, and resources.Mass spectral analysis of urine proteomic profiles of dairy cows suffering from clinical ketosis.Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function--the Tromsø study.Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease.Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells.Serum cathepsin S is associated with decreased insulin sensitivity and the development of type 2 diabetes in a community-based cohort of elderly menPerformance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.Endothelial cells and cathepsins: Biochemical and biomechanical regulation.The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults.Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease.Therapeutic inhibition of cathepsin K-reducing bone resorption while maintaining bone formation.GFR estimating equations: getting closer to the truth?Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular diseaseArchitecture and the extracellular matrix: the still unappreciated components of the adipose tissue.Cathepsin L activity correlates with proteinuria in chronic kidney disease in humans.Cysteine proteases in atherosclerosis.Matrix ageing and vascular impacts: focus on elastin fragmentation.Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans.Human cystatin C monomer, dimer, oligomer, and amyloid structures are related to health and disease.Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.Creatinine-Based and Cystatin C-Based GFR Estimating Equations and Their Non-GFR Determinants in Kidney Transplant Recipients.Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cellsAssociation of epicardial adipose tissue with serum level of cystatin C in type 2 diabetes.Decreased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability.Serum cystatin C and emphysema: results from the National Health and Nutrition Examination Survey (NHANES).The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease.Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease.PACMANS: A bioinformatically informed algorithm to predict, design, and disrupt protease-on-protease hydrolysis.Multiplex Cathepsin Zymography to Detect Amounts of Active Cathepsins K, L, S, and V.The role of cystatin C in vascular remodeling of balloon-injured abdominal aorta of rabbits.Serum cystatin C and prediabetes in non-obese US adults.The association between cystatin C and incident type 2 diabetes is related to central adiposity.Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization.Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial.Porphyromonas gingivalis and its lipopolysaccharide differentially regulate the expression of cathepsin B in endothelial cells.Chronic kidney disease: classification of CKD should be about more than prognosis.Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity.Elastin, arterial mechanics, and cardiovascular disease
P2860
Q28728934-48C7E12D-ACDB-4C42-A797-60CF73C5BECDQ30863658-024DAF04-3A0A-4FAC-853C-C3587C90BC72Q33439543-87E49117-BC03-4349-82C8-6F7FAD20B1B8Q35641886-A2D78DE9-879E-43F9-BCB7-59020C6AB8BEQ36094689-160C5B74-D575-435B-8E2D-36A8A7A7A013Q36211889-3558CEB9-4C89-4E67-B176-3BA42FACFE6EQ36276616-DDA404B4-696B-4B03-BEBD-913E971E6D84Q36477922-15C2238C-1245-4E6C-A17B-6E48AE35012CQ36501261-A9BCC589-368B-496F-9D19-B008F0D2F206Q36563605-78D4C3BA-3AAE-4265-BB1B-B4293E264108Q36621001-E6B1576B-3E3F-4E6A-B041-F4C10FDF5E73Q36867914-1C3253EA-9B05-42C0-A0DB-0EEBE27C069EQ37056336-36709FFD-B9EE-4CE5-BF2F-90A651E3E79EQ37065589-D295223E-D0E8-4042-AF32-47885FBAEF6AQ37568849-01EC6450-47FC-44EF-9491-86238A07E443Q37848921-DA4A48C7-825E-4450-BCFF-F128E62114C5Q38680372-111BBA3A-1418-4B86-8865-26DCF99601CBQ38756684-9CB712FE-8F17-4BB6-B9EC-C455E855D374Q38786598-BAEF8513-4BBD-40AF-867B-6FF64BC9C284Q38940277-6F50DA5B-5733-40EE-B885-445219990CF3Q38987127-C4EADFDC-E5E0-40F1-960C-66F3A5670501Q40322521-FC7708D7-06A6-4539-947F-33CBA7AA9A57Q40683910-6C7F8DC4-D2A6-4EF2-8384-52D0590BE72EQ41644080-C7A76CFA-4C8E-4D44-8B79-F306A965D758Q41702418-37B72A84-E3E4-4B7B-ADEF-EF76177112D9Q42376295-EC31FB8D-6CB1-4096-9846-91FC15DC561FQ43877569-426ED489-D78F-4C22-AFB2-31A532668313Q47171560-40933A9D-657A-40E6-A998-D0D9CAC91DD0Q47696609-8EE3561D-449E-4FF0-B916-805D21E6EF99Q48014081-E984F4DC-3183-4D06-A5DB-74BD006F4272Q48024252-871AF4F0-9695-4543-820E-58DE9153F793Q48851857-44029B16-8411-40EA-9256-5760DA2BF1D3Q51272947-A3B24E87-1CFE-4484-917C-9D4E57E149ADQ51346738-82027D8D-183E-4CFC-836D-F860699B1837Q53109387-0A33F493-293F-48AA-B9D4-FE1925A51996Q53518646-9AF052D2-ACA0-4920-AC79-BF8F13BB6ECFQ54313819-19098AAD-F2A9-43C6-8388-6D9F6E025FA9Q54760454-F97D85CB-071A-432D-BFFF-8328541480A0Q55265082-7086A01A-B7B8-4072-91D0-365596E34FA9Q57171390-71E6364E-468E-4CFE-BECE-2DDCD65F95E6
P2860
Cathepsins and cystatin C in atherosclerosis and obesity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cathepsins and cystatin C in atherosclerosis and obesity.
@en
Cathepsins and cystatin C in atherosclerosis and obesity.
@nl
type
label
Cathepsins and cystatin C in atherosclerosis and obesity.
@en
Cathepsins and cystatin C in atherosclerosis and obesity.
@nl
prefLabel
Cathepsins and cystatin C in atherosclerosis and obesity.
@en
Cathepsins and cystatin C in atherosclerosis and obesity.
@nl
P2093
P1433
P1476
Cathepsins and cystatin C in atherosclerosis and obesity.
@en
P2093
Jean-Charles Lafarge
Michèle Guerre-Millo
Nadia Naour
P304
P356
10.1016/J.BIOCHI.2010.04.011
P577
2010-04-24T00:00:00Z